These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 35313040)

  • 1. Association between social determinants of health and rates of liver transplantation in individuals with cirrhosis.
    Flemming JA; Muaddi H; Djerboua M; Neves P; Sapisochin G; Selzner N
    Hepatology; 2022 Oct; 76(4):1079-1089. PubMed ID: 35313040
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Individual and neighborhood socioeconomic status in the prediction of liver transplantation among patients with liver disease: A population-based cohort study in Taiwan.
    Liu CC; Lu CL; Notobroto HB; Tsai CC; Wen PH; Li CY
    Medicine (Baltimore); 2019 Mar; 98(11):e14849. PubMed ID: 30882681
    [TBL] [Abstract][Full Text] [Related]  

  • 3. De Novo Hepatocellular Carcinoma Among Liver Transplant Registrants in the Direct Acting Antiviral Era.
    Kwong AJ; Kim WR; Flemming JA
    Hepatology; 2018 Oct; 68(4):1288-1297. PubMed ID: 29672886
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Survival after radiofrequency ablation and salvage transplantation in patients with hepatocellular carcinoma and Child-Pugh A cirrhosis.
    N'Kontchou G; Aout M; Laurent A; Nahon P; Ganne-Carrié N; Grando V; Baghad I; Roulot D; Trinchet JC; Sellier N; Cherqui D; Vicaut E; Beaugrand M; Seror O
    J Hepatol; 2012 Jan; 56(1):160-6. PubMed ID: 21703186
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Salvage liver transplantation or repeat hepatectomy for recurrent hepatocellular carcinoma: An intent-to-treat analysis.
    Lim C; Shinkawa H; Hasegawa K; Bhangui P; Salloum C; Gomez Gavara C; Lahat E; Omichi K; Arita J; Sakamoto Y; Compagnon P; Feray C; Kokudo N; Azoulay D
    Liver Transpl; 2017 Dec; 23(12):1553-1563. PubMed ID: 28945955
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Poor Outcomes of Cirrhosis due to Nonalcoholic Steatohepatitis Compared With Hepatitis B After Decompensation With Ascites.
    Tan HK; Teng MLP; Soh AYS; Cheo SHY; Fook-Chong S; Goh GBB; Tan CK; Wong GW; Lee GH; Chang JPE
    Am J Gastroenterol; 2021 Jul; 116(7):1437-1446. PubMed ID: 33834737
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term effect of sustained virological response on hepatocellular carcinoma in patients with hepatitis C in Canada.
    Janjua NZ; Chong M; Kuo M; Woods R; Wong J; Yoshida EM; Sherman M; Butt ZA; Samji H; Cook D; Yu A; Alvarez M; Tyndall M; Krajden M
    J Hepatol; 2017 Mar; 66(3):504-513. PubMed ID: 27818234
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Liver Transplantation and Liver Resection for Cirrhotic Patients with Hepatocellular Carcinoma: Comparison of Long-Term Survivals.
    Krenzien F; Schmelzle M; Struecker B; Raschzok N; Benzing C; Jara M; Bahra M; Öllinger R; Sauer IM; Pascher A; Pratschke J; Andreou A
    J Gastrointest Surg; 2018 May; 22(5):840-848. PubMed ID: 29363019
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combination of racial/ethnic and etiology/disease-specific factors is associated with lower survival following liver transplantation in African Americans: an analysis from UNOS/OPTN database.
    Wong RJ; Ahmed A
    Clin Transplant; 2014 Jul; 28(7):755-61. PubMed ID: 24750171
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Liver transplantation for hepatitis B virus: Decreasing indication and changing trends.
    Al-Hamoudi W; Elsiesy H; Bendahmash A; Al-Masri N; Ali S; Allam N; Al Sofayan M; Al Bahili H; Al Sebayel M; Broering D; Saab S; Abaalkhail F
    World J Gastroenterol; 2015 Jul; 21(26):8140-7. PubMed ID: 26185387
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Disability in patients with end-stage liver disease: Results from the functional assessment in liver transplantation study.
    Samoylova ML; Covinsky KE; Haftek M; Kuo S; Roberts JP; Lai JC
    Liver Transpl; 2017 Mar; 23(3):292-298. PubMed ID: 27884053
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recovery From Dialysis-Treated Acute Kidney Injury in Patients With Cirrhosis: A Population-Based Study.
    Wang PL; Silver SA; Djerboua M; Thanabalasingam S; Zarnke S; Flemming JA
    Am J Kidney Dis; 2022 Jul; 80(1):55-64.e1. PubMed ID: 34808296
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Health care costs associated with chronic hepatitis C virus infection in Ontario, Canada: a retrospective cohort study.
    Wong WWL; Haines A; Bremner KE; Yao Z; Calzavara A; Mitsakakis N; Kwong JC; Sander B; Thein HH; Krahn MD
    CMAJ Open; 2021; 9(1):E167-E174. PubMed ID: 33688024
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk factors of de novo malignancies after liver transplantation: a French national study on 11004 adult patients.
    Altieri M; Sérée O; Lobbedez T; Segol P; Abergel A; Blaizot X; Boillot O; Boudjema K; Coilly A; Conti F; Chazouillères O; Debette-Gratien M; Dharancy S; Durand F; Duvoux C; Francoz C; Gugenheim J; Hardwigsen J; Houssel-Debry P; Kamar N; Latournerie M; Lebray P; Leroy V; Neau-Cransac M; Pageaux GP; Radenne S; Salamé E; Saliba F; Samuel D; Vanlemmens C; Besch C; Launoy G; Dumortier J
    Clin Res Hepatol Gastroenterol; 2021 Jul; 45(4):101514. PubMed ID: 33714907
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ursodeoxycholic Acid Response Is Associated With Reduced Mortality in Primary Biliary Cholangitis With Compensated Cirrhosis.
    John BV; Khakoo NS; Schwartz KB; Aitchenson G; Levy C; Dahman B; Deng Y; Goldberg DS; Martin P; Kaplan DE; Taddei TH
    Am J Gastroenterol; 2021 Sep; 116(9):1913-1923. PubMed ID: 33989225
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association Between Sarcopenia and AFP Level in Patients Undergoing Liver Transplantation for Hepatocellular Carcinoma.
    Acosta LF; Galuppo R; García CR; Villacorta E; Dugan A; Castellanos AL; Gedaly R; Lee JT
    J Surg Res; 2019 Jun; 238():10-15. PubMed ID: 30721781
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rates of surveillance and management of hepatocellular carcinoma in patients evaluated at a liver transplant center.
    Jou JH; Chen PH; Jazwinski A; Bouneva I; Smith AD; Muir AJ
    Dig Dis Sci; 2010 Dec; 55(12):3591-6. PubMed ID: 20683659
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preoperative predictors of non-transplantable recurrence after resection for early-stage hepatocellular carcinoma: application in an East Asian cohort.
    Li WF; Yen YH; Liu YW; Wang CC; Yong CC; Lin CC
    Updates Surg; 2022 Jun; 74(3):891-897. PubMed ID: 35023038
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cirrhosis and microvascular invasion predict outcomes in hepatocellular carcinoma.
    Barreto SG; Brooke-Smith M; Dolan P; Wilson TG; Padbury RT; Chen JW
    ANZ J Surg; 2013 May; 83(5):331-5. PubMed ID: 22943449
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatocellular carcinoma developed on compensated cirrhosis: resection as a selection tool for liver transplantation.
    Scatton O; Zalinski S; Terris B; Lefevre JH; Casali A; Massault PP; Conti F; Calmus Y; Soubrane O
    Liver Transpl; 2008 Jun; 14(6):779-88. PubMed ID: 18508370
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.